Pharma Strikes Out At Supreme Court As Three Recent Cert Petitions Fail
This article was originally published in The Pink Sheet Daily
Pfizer, Cephalon and former InterMune CEO Scott Harkonen will find no relief from the high court.
You may also be interested in...
After losing patent infringement suit against Merus involving antibody-producing mouse, Regeneron fights ruling that it withheld material information in prosecuting the patent.
Seventh Circuit reinstates employer benefit funds’ complaint over off-label promotion of Depakote, allowing them to make case they were not properly compensated; courts have issued disparate opinions in such cases.
High court declines to intervene in dispute over Arizona law that would restrict use of abortion drug; court also denies Roche petition for review of Boniva patent ruling.